ARTIS Ventures

Type

Venture Capital

Status

Active

Location

San Francisco, United States

Total investments

119

Average round size

39M

Portfolio companies

74

Rounds per year

5.17

Lead investments

20

Follow on index

0.37

Exits

23

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceMachine LearningHealth CareSaaSMedicalLife ScienceTherapeutics

Summary

Artis Ventures (AV) is the famous VC, which was founded in 2005. The company was established in North America in United States. The main department of described VC is located in the San Francisco.

Among the most popular fund investment industries, there are Enterprise Software, Software. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the various public portfolio startups of the fund, we may underline Facebook, Palantir Technologies, Stemcentrx

This organization was formed by Mike Harden, Stuart Peterson. We also calculated 5 valuable employees in our database.

The increased amount of exits for fund were in 2011. The fund is constantly included in 2-6 investment rounds annually. Opposing the other organizations, this Artis Ventures (AV) works on 1 percentage points less the average amount of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Artis Ventures (AV) the average startup value is more than 1 billion dollars. Speaking about the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2014. Despite it in 2019 the fund had an activity.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Artis Ventures (AV), startups are often financed by Norwest Venture Partners, Morgenthaler Ventures, Greylock Partners. The meaningful sponsors for the fund in investment in the same round are Founders Fund, Abstract Ventures, Oakhouse Partners. In the next rounds fund is usually obtained by Founders Fund, Morgenthaler Ventures, Worldview Technology Partners.

Show more

Investor highlights

Industry focus
AI/Big DataBiotech/Life SciencesMedtechHealthcare
Stage focus
Series ASeries B
Check size
Up to 10M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 200000000
Fund raised date
2023-12-14

Analytics

Total investments
119
Lead investments
20
Exits
23
Rounds per year
5.17
Follow on index
0.37
Investments by industry
  • Health Care (39)
  • Biotechnology (36)
  • Software (30)
  • Artificial Intelligence (19)
  • Therapeutics (16)
  • Show 129 more
Investments by region
  • United States (115)
  • United Kingdom (1)
  • India (1)
Peak activity year
2021
Number of Unicorns
6
Number of Decacorns
7
Number of Minotaurs
3

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
556M
Group Appearance index
0.89
Avg. company exit year
9
Avg. multiplicator
2.58
Strategy success index
0.70

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
OverT Bio 06 May 2024 Seed 16M United States, New York, New York
Siren Biotechnology 17 May 2023 Biotechnology, Medical, Product Research Seed United States, California, San Francisco

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.